Guselkumab - In Psoriasis and Beyond

• Những tác giả chính: Aditya Kumar Bubna (Tác giả), Vinayak Viplav (Tác giả)
• Định dạng: Sách
• Được phát hành: Mattioli1885, 2024-07-01T00:00:00Z.
• Những chủ đề: article
• Truy cập trực tuyến: Connect to this object online.

Introduction: Guselkumab is an interleukin 23p19 inhibitor, and the first in this group, to be approved by the US Food and Drug Administration (FDA) for the management of moderate to severe psoriasis. Apart from its utility in psoriasis, there are a number of other dermatologic conditions where guse...